ZA200707420B - Methods and reagents for treatment and diagnosis of age-related macular degeneration - Google Patents
Methods and reagents for treatment and diagnosis of age-related macular degenerationInfo
- Publication number
- ZA200707420B ZA200707420B ZA200707420A ZA200707420A ZA200707420B ZA 200707420 B ZA200707420 B ZA 200707420B ZA 200707420 A ZA200707420 A ZA 200707420A ZA 200707420 A ZA200707420 A ZA 200707420A ZA 200707420 B ZA200707420 B ZA 200707420B
- Authority
- ZA
- South Africa
- Prior art keywords
- reagents
- diagnosis
- age
- treatment
- methods
- Prior art date
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65307805P | 2005-02-14 | 2005-02-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200707420B true ZA200707420B (en) | 2009-04-29 |
Family
ID=39307957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200707420A ZA200707420B (en) | 2005-02-14 | 2006-02-14 | Methods and reagents for treatment and diagnosis of age-related macular degeneration |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101160412A (en) |
| ZA (1) | ZA200707420B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102834410B (en) * | 2010-03-30 | 2016-10-05 | 奥克兰儿童医院及研究中心 | Modified H factor bindin (FHBP) and using method thereof |
| CN102978204B (en) * | 2011-11-11 | 2018-06-08 | 张康 | The assay kit and assay method of CFHR1 and oxidation phosphocholine in CFHR1 genotype, high-density lipoprotein |
| US9701743B2 (en) * | 2014-02-20 | 2017-07-11 | Allergan, Inc. | Complement component C5 antibodies |
| IL304203B2 (en) * | 2014-02-26 | 2024-10-01 | Xencor Inc | Complementary component 5C antibodies |
| CN106715464B (en) | 2014-07-23 | 2021-03-16 | 奥克兰儿童医院及研究中心 | Factor H binding protein variants and methods of use |
| CN114685453A (en) * | 2016-06-21 | 2022-07-01 | 奥瑞恩眼科有限责任公司 | Heterocyclic prolinamide derivatives |
| US20210246507A1 (en) * | 2018-05-10 | 2021-08-12 | The University Of Manchester | Methods for assessing macular degeneration |
| GB201821089D0 (en) * | 2018-12-21 | 2019-02-06 | Gyroscope Therapeutics Ltd | Codon-optimised complement factor I |
| CA3158517A1 (en) * | 2019-10-22 | 2021-04-29 | Applied Genetic Technologies Corporation | Adeno-associated virus (aav)vectors for the treatment of age-related macular degeneration and other ocular diseases and disorders |
-
2006
- 2006-02-14 CN CNA2006800124949A patent/CN101160412A/en active Pending
- 2006-02-14 ZA ZA200707420A patent/ZA200707420B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101160412A (en) | 2008-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200809493B (en) | Method of treatment of age-related macular degeneration (AMD) | |
| IL196016A0 (en) | Diagnosis and treatment of age related macular degeneration | |
| ZA200707420B (en) | Methods and reagents for treatment and diagnosis of age-related macular degeneration | |
| PL2508182T3 (en) | Hydralazine for use in the treatment of age-related macular degeneration | |
| ZA200710371B (en) | Compositions and methods for treating hyperproliferative epidermal diseases | |
| GB2421433B (en) | Use of compositions for treating age related macular degeneration or dystrophy | |
| IL233634A0 (en) | Methods, compositions, and kits for the treatment of medical conditions | |
| IL187553A0 (en) | Methods of treating cancer and other conditions or disease states using lfmau and ldt | |
| HK1171972A1 (en) | Methods and products for treatment of diseases | |
| IL188728A0 (en) | Methods of treating epileptogenesis | |
| GB0608647D0 (en) | Methods of diagnosis and treatment | |
| IL173971A0 (en) | Compositions and methods for treating and preventing age-related macular degeneration | |
| IL187715A0 (en) | Use of phenylsemicarbazones for seed treatment | |
| EP2083841A4 (en) | Treatment for age-related macular degeneration and other diseases of the eye | |
| EP1866647A4 (en) | A method of diagnosis and treatment and agents useful for same | |
| ZA200808363B (en) | Compounds and methods for diagnosis and treatment of leishmaniasis | |
| EP1937197A4 (en) | Method and device for the macular degeneration treatment | |
| GB0625844D0 (en) | The treatment of macular degeneration | |
| GB2442881B (en) | Methods for altering gene expression and methods of treatment utilizing same | |
| EP1962882A4 (en) | Compositions and methods for treatment of diabetes | |
| ZA200800393B (en) | Use of phenylsemicarbazones for seed treatment | |
| IL196173A0 (en) | Use of agents that act on t cells for treatment of age-related macular degeneration | |
| GB0512568D0 (en) | Method of diagnosis and treatment | |
| IL179922A0 (en) | Method for sterilization of biological preparations | |
| GB0526423D0 (en) | Treatment of protein aggregation diseases |